Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.46 USD | +0.94% | -6.86% | -9.86% |
Apr. 11 | Harmony Biosciences, Bioprojet Enter Licensing Deal for Sleep Disorder Therapy | MT |
Apr. 03 | Harmony Biosciences Begins Phase 3 Trial of Pitolisant to Treat Prader-Willi Syndrome Symptoms | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.86% | 1.66B | |
+28.56% | 676B | |
+24.21% | 554B | |
-7.86% | 349B | |
+14.50% | 318B | |
+6.67% | 291B | |
+2.97% | 210B | |
-0.40% | 204B | |
-9.98% | 194B | |
-11.67% | 144B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Harmony Biosciences to be Included in Nasdaq Biotechnology Index